These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. Nelson KK; Schlöndorff J; Blobel CP Biochem J; 1999 Nov; 343 Pt 3(Pt 3):673-80. PubMed ID: 10527948 [TBL] [Abstract][Full Text] [Related]
3. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. Amour A; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Stephens PE; Shelley C; Hutton M; Knäuper V; Docherty AJ; Murphy G FEBS Lett; 1998 Sep; 435(1):39-44. PubMed ID: 9755855 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25. Cerretti DP; Poindexter K; Castner BJ; Means G; Copeland NG; Gilbert DJ; Jenkins NA; Black RA; Nelson N Cytokine; 1999 Aug; 11(8):541-51. PubMed ID: 10433800 [TBL] [Abstract][Full Text] [Related]
5. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Black RA; Rauch CT; Kozlosky CJ; Peschon JJ; Slack JL; Wolfson MF; Castner BJ; Stocking KL; Reddy P; Srinivasan S; Nelson N; Boiani N; Schooley KA; Gerhart M; Davis R; Fitzner JN; Johnson RS; Paxton RJ; March CJ; Cerretti DP Nature; 1997 Feb; 385(6618):729-33. PubMed ID: 9034190 [TBL] [Abstract][Full Text] [Related]
6. Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine-rich/disintegrin domains of the tumor necrosis factor-alpha converting enzyme (TACE). Li X; Fan H J Biol Chem; 2004 Jun; 279(26):27365-75. PubMed ID: 15075334 [TBL] [Abstract][Full Text] [Related]
7. Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing. Merlos-Suárez A; Fernández-Larrea J; Reddy P; Baselga J; Arribas J J Biol Chem; 1998 Sep; 273(38):24955-62. PubMed ID: 9733803 [TBL] [Abstract][Full Text] [Related]
8. Purification of ADAM 10 from bovine spleen as a TNFalpha convertase. Lunn CA; Fan X; Dalie B; Miller K; Zavodny PJ; Narula SK; Lundell D FEBS Lett; 1997 Jan; 400(3):333-5. PubMed ID: 9009225 [TBL] [Abstract][Full Text] [Related]
9. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion. Solomon KA; Pesti N; Wu G; Newton RC J Immunol; 1999 Oct; 163(8):4105-8. PubMed ID: 10510344 [TBL] [Abstract][Full Text] [Related]
11. Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form. Itai T; Tanaka M; Nagata S Eur J Biochem; 2001 Apr; 268(7):2074-82. PubMed ID: 11277930 [TBL] [Abstract][Full Text] [Related]
12. Expression and purification of correctly processed, active human TACE catalytic domain in Saccharomyces cerevisiae. Clarke HR; Wolfson MF; Rauch CT; Castner BJ; Huang CP; Gerhart MJ; Johnson RS; Cerretti DP; Paxton RJ; Price VL; Black RA Protein Expr Purif; 1998 Jun; 13(1):104-10. PubMed ID: 9631522 [TBL] [Abstract][Full Text] [Related]
13. Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). Moss ML; Jin SL; Becherer JD; Bickett DM; Burkhart W; Chen WJ; Hassler D; Leesnitzer MT; McGeehan G; Milla M; Moyer M; Rocque W; Seaton T; Schoenen F; Warner J; Willard D J Neuroimmunol; 1997 Feb; 72(2):127-9. PubMed ID: 9042103 [TBL] [Abstract][Full Text] [Related]
14. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain. Zolkiewska A Exp Cell Res; 1999 Nov; 252(2):423-31. PubMed ID: 10527632 [TBL] [Abstract][Full Text] [Related]
15. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Mohan MJ; Seaton T; Mitchell J; Howe A; Blackburn K; Burkhart W; Moyer M; Patel I; Waitt GM; Becherer JD; Moss ML; Milla ME Biochemistry; 2002 Jul; 41(30):9462-9. PubMed ID: 12135369 [TBL] [Abstract][Full Text] [Related]
16. Expression and function of tumour necrosis factor-alpha-converting enzyme in the central nervous system. Moro MA; Hurtado O; Cárdenas A; Romera C; Madrigal JL; Fernández-Tomé P; Leza JC; Lorenzo P; Lizasoain I Neurosignals; 2003; 12(2):53-8. PubMed ID: 12876399 [TBL] [Abstract][Full Text] [Related]
17. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases. Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445 [TBL] [Abstract][Full Text] [Related]
18. Expression and localization of tumour necrosis factor-alpha and its converting enzyme in human abdominal aortic aneurysm. Satoh H; Nakamura M; Satoh M; Nakajima T; Izumoto H; Maesawa C; Kawazoe K; Masuda T; Hiramori K Clin Sci (Lond); 2004 Mar; 106(3):301-6. PubMed ID: 14580234 [TBL] [Abstract][Full Text] [Related]
19. Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE). Killar L; White J; Black R; Peschon J Ann N Y Acad Sci; 1999 Jun; 878():442-52. PubMed ID: 10415747 [TBL] [Abstract][Full Text] [Related]
20. Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis. Satoh M; Nakamura M; Satoh H; Saitoh H; Segawa I; Hiramori K J Am Coll Cardiol; 2000 Oct; 36(4):1288-94. PubMed ID: 11028485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]